RespireRx Pharmaceuticals Inc (RSPI)

[gfp927z]

MarketFest, I'm not ruling out the possibility that something underhanded is going on here, with the FDA favoring the interests of large pharmas like Lilly and Glaxo. The regulators are only human, and large pharma companies have a lot more clout than small fry like Cortex. It's not impossible that strings are being pulled behind the scenes, though one would hope that's not the case. More likely, the FDA is just being hypercritical at a time when they're under severe criticism, especially with ADHD related drugs. The neuro division is also currently in disarray since it's recently been split into two separate divisions.

I got a taste of just how petty and biased the FDA can be (or appear to be) when listening to a webcast of an FDA panel considering Celgene's Revlimid several years ago. Amazingly, this was actually webcast. The FDA panel members sounded anything but objective, with some sounding like Celgene lackeys, and others like they hated Celgene's guts and had it in for them. Not exactly the high minded objectivity one would want from a regulatory agency dealing with important life saving medicines.